Notably, in both Cancer Genomic Atlas (TCGA) and CCLE databases, the meiotic gene SYCP2 is commonly upregulated in breast, cervical, and ovarian cancers and also detected in other cancer types, including lung, head-and-neck, and bladder cancers (Fig. 1B). This evidence concerns the gene SYCP2 and cancer.